Skip to main content
Login | Suomeksi | På svenska | In English

Browsing by Subject "mutation"

Sort by: Order: Results:

  • Qadri, Sami; Anttonen, Olli; Viikilä, Juho; Seppälä, Eija H.; Myllykangas, Samuel; Alastalo, Tero-Pekka; Holmström, Miia; Heliö, Tiina; Koskenvuo, Juha W. (2018)
    BACKGROUND Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited cardiac disease, involving changes in ventricular myocardial tissue and leading to fatal arrhythmias. Mutations in desmosomal genes are thought to be the main cause of ARVC. However, the exact molecular genetic etiology of the disease still remains largely inconclusive, and this along with large variabilities in clinical manifestations complicate clinical diagnostics. CASE PRESENTATION We report two families (n = 20) in which a desmoglein-2 (DSG2) missense variant c.1003A > G, p.(Thr335Ala) was discovered in the index patients using next-generation sequencing panels. The presence of this variant in probands’ siblings and children was studied by Sanger sequencing. Five homozygotes and nine heterozygotes were found with the mutation. Participants were evaluated clinically where possible, and available medical records were obtained. All patients homozygous for the variant fulfilled the current diagnostic criteria for ARVC, whereas none of the heterozygous subjects had symptoms suggestive of ARVC or other cardiomyopathies. CONCLUSIONS The homozygous DSG2 variant c.1003A > G co-segregated with ARVC, indicating autosomal recessive inheritance and complete penetrance. More research is needed to establish a detailed understanding of the relevance of rare variants in ARVC associated genes, which is essential for informative genetic counseling and rational family member testing.
  • Tanskanen, Tomas (2013)
    Objective. Early-onset colorectal cancer (CRC), defined here as age of onset less than 40 years, develops frequently in genetically predisposed individuals. Next-generation sequencing is an increasingly available option in the diagnostic workup of suspected hereditary susceptibility, but little is known about the practical feasibility and additional diagnostic yield of the technology in this patient group. Materials and methods. We analyzed 38 young CRC patients derived from a set of 1514 CRC cases. All 38 tumors had been tested in our laboratory for microsatellite instability (MSI), and Sanger sequencing had been used to screen for MLH1 and MSH2 mutations in MSI cases. Also, gastrointestinal polyposis had been diagnosed clinically and molecularly. Family histories were acquired from national registries. If inherited syndromes had not been diagnosed in routine diagnostic efforts (n = 23), normal tissue DNA was analyzed for mutations in a comprehensive set of high-penetrance genes (MLH1, MSH2, MSH6, PMS2, APC, MUTYH, SMAD4, BMPR1A, LKB1/STK11, and PTEN) by exome sequencing. Results. CRC predisposition syndromes were confirmed in 42% (16/38) of early-onset CRC patients. Hereditary nonpolyposis colorectal cancer was diagnosed in 12 (32%) patients, familial adenomatous polyposis in three (7.9%), and juvenile polyposis in one (2.6%) patient. Exome sequencing revealed one additional MLH1 mutation. Over half of the patients had advanced cancers (Dukes C or D, 61%, 23/38). The majority of nonsyndromic patients had unaffected first-degree relatives and microsatellite-stable tumors. Conclusions. Microsatellite instability positivity or gastrointestinal polyposis characterized all patients with unambiguous highly penetrant germline mutations. In our series, exome sequencing produced little added value in diagnosing the underlying predisposition conditions.
  • Karhu, Thomas (2016)
    The main focus of this study is a Finnish family, in which four out of eight children presented with an unidentified disease causing a grave developmental disorder. A genetic cause for this disorder was sought by utilizing whole exome sequencing. Both parents, two affected siblings and one healthy sibling were sequenced. After variant filtering and analysis, only the candidate gene UBA5 passed the filtering criteria. The results were validated using Sanger sequencing. Both affected individuals were shown to have compound heterozygous variants of this gene, with one of the variants being novel. No cases of disease in humans associated with UBA5 have prior to this study been reported. However, other unrelated patients with a similar phenotype have since been found to possess pathogenic variants in the gene UBA5, which confirms the claim that it's the disease-causing gene. Therefore, this study enhances our knowledge of the gene's physiological significance.
  • Mikkola, Annamari (2018)
    Tutkimuksen kohteena on suomalainen suku, jossa esiintyy hampaiden kovakudosten perinnöllinen kehityshäiriö. Aikaisemmissa tutkimuksissa kehityshäiriön aiheuttava mutaatio on paikallistettu kromosomiin 15, ja kahden näytteen eksomisekvensoinnilla on löydetty useita mahdollisia mutaatioita. Tähän tutkimukseen on valittu näistä mutaatioista seitsemän tarkempaa tutkimista varten. Tutkittavaksi valitut mutaatiot sijaitsevat geeneissä OTUD7A, SPTBN5 (2 mutaatiota), PLA2G4F, FLJ27352, PRTG ja IGDCC4. Tarkoituksena on selvittää, esiintyvätkö ne kaikilla sairailla suvun jäsenillä ja voivatko ne olla kehityshäiriön taustalla. Aluksi tutkittavaksi valittiin neljä suvun jäsentä, joilla on todettu hampaiden kehityshäiriö. Heidän DNA-näytteilleen tehtiin polymeraasiketjureaktio (PCR), geelielektroforeesi ja sekvensointi. Kaksi etsityistä mutaatioista löytyi kaikilta näiltä henkilöiltä, ja ne sijaitsivat geeneissä IGDCC4 ja PRTG. Seuraavassa vaiheessa PRTG- ja IGDCC-geenien mutaatioita etsittiin laajemmalta joukolta suvun jäseniä. Tutkittavia näytteitä oli yhteensä 15. Näytteistä kahdeksan oli sairailta suvun jäseniltä, yksi oletetusti sairaalta ja kuusi terveiltä. Geenin IGDCC4 mutaatio löytyi kahdeksalta sairaalta heterotsygoottisena, mutta ei mahdollisesti sairaalta suvun jäseneltä. Lisäksi se löytyi yhdeltä terveeltä. Näin ollen tämä mutaatio ei ole kehityshäiriön taustalla. Geenin PRTG mutaatio löytyi kaikilta sairailta heterotsygoottisena eikä sitä löytynyt yhdeltäkään terveeltä, joten periaatteessa tämä voisi olla kehityshäiriön taustalla. Se aiheuttaa missense-mutaation, joka muuttaa valiinin leusiiniksi. Uusimpien tietokantojen mukaan sen yleisyys erityisesti Suomessa on kuitenkin jopa 0,015, joten on epätodennäköistä, että tämäkään mutaatio ainakaan yksin aiheuttaisi tutkimuksen kohteena olevan hampaiden kovakudosten kehityshäiriön. Tutkimuksen kohteena olevan kehityshäiriön aiheuttavan mutaation selvittämiseksi tarvitaan siis jatkotutkimuksia. (217 sanaa)
  • Yang, Xiaochang (2019)
    Campylobacter jejuni is one of the leading causes of human gastroenteritis. Globally, there has been an increasing trend in the incidence of campylobacteriosis. In the European Union, about 200,000 cases of campylobacteriosis are reported annually. C. jejuni 4031 was isolated from a water outbreak in Finland. This strain belongs to the ST-45 clonal complex. According to a previous study, this population has been stable over time and space and has showed low levels of genomic diversity compared with other populations. Therefore, it is meaningful to investigate the evolutionary mechanisms and ecological conditions behind these clones. The aim of this study was to investigate the evolution of C. jejuni 4031 by whole genome sequencing and bioinformatics tools, characterizing the rate and molecular spectrum of spontaneous mutation in these clones. In addition, the transformation pattern of C. jejuni 4031 was to be studied. This study composed of three independent experiments: mutation accumulation experiment, fluctuation analysis, and transformation cycle experiment, to investigate mutation and recombination events, respectively. The C. jejuni 4031 grown for 220 generations by single colony passaging method in NB2 agar plate and thereafter named C. jejuni 4031x12 was used as starting material for the studies. In total of 76 genomes from both mutation accumulation experiments and transformation cycle experiments, were subject to SNP calling. Results showed that C. jejuni 4031x12 could accumulate spontaneous mutations at a relatively low rate (4.1x10-10 mutation per generation per nucleotide) than conventional estimates, with mutational bias towards G:C>A:T transitions and coding regions. The fluctuation analysis proves that C. jejuni 4031x12 could obtain antibiotic resistance via transformation. However, no recombination events were observed from SNP results. In conclusion, C. jejuni 4031 has evolved at a much lower rate compared with prior knowledge. Results from fluctuation analysis and transformation cycle experiment suggest that there are no essential recombination barriers between C. jejuni 4031 and C. jejuni NCTC11168 but transformants may not have a competitive advantage over their non-transformed counterparts.